Clinical Trials · NCT02972060
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Enrollment
- 61
- Start date
- Dec 2017
- Locations
- 12 sites, 4 countries
- Primary endpoint
- PSA response